Blog - Page 3754 of 5742

WednesdaySep 22, 2010 2:02 pm

Greenlight Resources Inc. (PRZCF) Provides Update on Lithium Project in Canada

Greenlight Resources Inc. issued an update on the development program at its properties in Canada, where the company is conducting phase one testing of the mineral potential of the area. Greenlight Resources Inc. has interests in the Brazil Lake Lithium and Rare Metal property located north of Yarmouth, Nova Scotia. The company has drilled a total of fourteen cored holes in order to assess the mineral component of its property. The total core sample length obtained to date is 1,829 meters with another 400 meters left in phase one. Greenlight Resources Inc. is looking for lithium deposits of sufficient size…

WednesdaySep 22, 2010 2:00 pm

RXi Pharmaceuticals Corp. (RXII) Partners with EyeGate to Advance Ocular Treatment Technology

RXi Pharmaceuticals Corp. has developed a comprehensive therapeutic platform based on RNA interference (RNAi) therapeutics to treat a number of diseases, scarring and retinal disorders. The company today announced its partnership with EyeGate Pharma, a leader in non-invasive ocular drug delivery, to collaborate on the ocular delivery of RNAi therapeutics. Per the agreement, both companies will contribute technology, expertise, and resources to develop ocular treatments. "The development of RNAi therapeutics to treat retinal disorders is a key focus for our company, and we are excited to be collaborating with EyeGate to explore new, patient friendly approaches for delivering RNAi therapeutics…

WednesdaySep 22, 2010 11:30 am

Curaxis Pharmaceutical Corp. (CURX.OB) Enters Into Equity Line Agreement with Southridge Partners

Curaxis Pharmaceutical Corp. is an emerging specialty pharmaceutical company with a hormone drug product candidate for the treatment of Alzheimer's disease and also multiple cancers. The company's therapeutic platform is based on the hypothesis that many diseases of aging may be caused by age-related changes in the function of a hormonal endocrine feedback loop that controls development, reproduction and aging in animals. The premise is that hormones associated with the feedback loop are beneficial early in life when they promote growth and development, but are harmful later in life when the mechanism for feedback is compromised. Curaxis announced today that…

WednesdaySep 22, 2010 11:28 am

Protectus Medical Devices, Inc. (PTMD.PK) Obtains U.S. Patent for Self-Sheathing Safety Syringe

Protectus Medical Devices, Inc. is proving to be a company on the move. Located in Minneapolis, Minnesota, Protectus, formerly known as E-18 Corp., operates through its wholly-owned subsidiary SquareOne Medical which develops and markets innovative safety medical devices that have the potential to drastically reduce needlestick injuries for medical professionals across the globe. Today, Protectus Medical took a major step towards prominence with the announcement they have received a U.S. Patent for its self-sheathing safety syringe. The patent which was granted by the U.S. Patent and Trademark Office is No. 7,799,002. This patent will provide 20 years of patent protection…

WednesdaySep 22, 2010 11:22 am

eDoorways Corp. (EDWY.PK) Creates PowerChannel for ISTEC Assembly in Brazil

eDoorways Corp. recently announced that it has been commissioned to develop a PowerChannel in support of delegates attending the ISTEC (Ibero-American Science Technology Education Consortium) 2010 General Assembly being held later this year in Brazil. The PowerChannel (basically a function-rich communication platform) will provide ISTEC attendees unprecedented event collaboration capabilities. Attendees are expected from a wide range of organizations, municipalities, and universities, representing 28 Latin American countries, as well as Spain and Portugal. eDoorways CEO, Gary Kimmons, commented on what the opportunity means for his company: “We have a rare opportunity to do something that’s never been done before. We…

WednesdaySep 22, 2010 10:16 am

Alpha Pro Tech Ltd. (APT) Video Chart for Wednesday, September 22, 2010

The APT chart has continued to create bottoms and slip through. However, over the past couple months, it has established a new base and made higher lows. It is now on radar as it attempts to step up to the next level. Please click the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

WednesdaySep 22, 2010 9:18 am

Axion International (AXIH.OB) Adds to Their Board of Directors

Axion International announced yesterday that Perry Jacobson, Managing Director at Brookstone Partners, and Michael Dodd, CEO of 3D Global Solutions, were elected to Axion’s Board of Directors. After several years of valuable service, Axion Board member, Lori Jones, has resigned from Axion’s Board. The Company stated that they wish her success and appreciate her contribution. Jim Kerstein, Axion CEO and Co-founder, stated, “Perry and Mike are going to be tremendous assets to Axion as we continue to grow the company. Perry’s insights and experience in the capital markets and Mike’s experience in management consulting and working with Military purchasing will…

WednesdaySep 22, 2010 8:52 am

Simulated Environment Concepts, Inc.’s (SMEV.PK) SpaCapsule May Offer More Medical Benefits Than Expected

Simulated Environment Concepts (SE Concepts), manufacturer and developer of medical, aesthetic and wellness equipment, announced this morning that the Dermscan Group is almost finished with its clinical trial research on the SpaCapsule and the equipment's medical benefits. Dr. Ella Frenkel, Chairman and CEO of Simulated Environment Concepts, Inc. stated, "SE Concepts tirelessly strives to develop products which return dividends to our customers by way of overall improved health. The Spa Capsule does just that. In allowing users to not only feel de-stressed and refreshed after each therapeutic session, but internally renewed, we're able to deliver a product to the medical…

WednesdaySep 22, 2010 8:07 am

VizStar, Inc. (VIZS.OB) Announces Significant Increase in Average Revenue Per Trip

VizStar, Inc. announced this morning that the average revenue per trip for the first three weeks of this fall is up 37.3% at $19,051.75 compared to the summer season's average of $14,358.60. The jet charter services industry's busiest season is usually the fall. Gary Clyburn Jr., CEO of VizStar, commented, "We anticipate increases in both trip size and frequency to continue. Celestial Jets' unique position in the space is attractive to new customers and is what keeps our frequent flyers flying. We expect our unparalleled service and value to help us further capitalize on this season's demand." Let us hear…

TuesdaySep 21, 2010 2:30 pm

Interleukin Genetics, Inc. (ILIU.QB) Details Findings of Huge Osteoarthritis Study

Interleukin Genetics, www.ilgenetics.com – developer of the Inherent Health® brand of genetic test systems like the proprietary PST® genetic risk panel for periodontal disease and susceptibility to tooth loss and the Weight Management Genetic Test for determining ideal exercise/diet based on personal genetics, announced exciting Osteoarthritis (OA) findings today in conjunction with the Thurston Arthritis Research Center at the University of North Carolina at Chapel Hill. Data from the large clinical study, which was aimed at quantifying the role genetic factors play in the progression of osteoarthritis, indicates a nearly doubled propensity for the disease to progress to a “severe”…

Site Search

Company Search